The complex interplay between cholesterol and prostate malignancy
- PMID: 21798387
- PMCID: PMC3146741
- DOI: 10.1016/j.ucl.2011.04.001
The complex interplay between cholesterol and prostate malignancy
Abstract
Research into the role of cholesterol and prostate disease has been ongoing for many years, but our mechanistic and translational understanding is still poor. Recent evidence indicates that cholesterol-lowering drugs reduce the risk of aggressive prostate cancer. This article reviews the literature on the relationship between circulating cholesterol and prostate cancer. The data strongly point to hypercholesterolemia as a risk factor for prostate cancer progression and suggest clinical opportunities for the use of cholesterol-lowering therapies to alter disease course.
Copyright © 2011 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures


References
-
- White RM. On the occurance of crystals in tumours. J Pathol Bacteriol. 1909;13:3–10.
-
- Schaffner CP. Prostatic cholesterol metabolism: regulation and alteration. Prog Clin Biol Res. 1981;75A:279–324. - PubMed
-
- Pearce ML, Dayton S. Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet. 1971;1(7697):464–7. - PubMed
-
- Ederer F, Leren P, Turpeinen O, Frantz ID., Jr Cancer among men on cholesterol-lowering diets: Experience from five clinical trials. Lancet. 1971;2(7717):203–6. - PubMed
-
- Miettinen M, Turpeinen O, Karvonen MJ, Elosuo R, Paavilainen E. Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet. 1972;2(7782):835–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical